Bridge to Life Ltd. Receives Breakthrough Device Designation from the FDA
/PRNewswire/ -- Bridge to Life, Ltd. ("Bridge to Life" or the "Company"), a leading global supplier of organ preservation solutions and organ perfusion...
Stay updated with breaking news from Perfusion Solution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Bridge to Life, Ltd. ("Bridge to Life" or the "Company"), a leading global supplier of organ preservation solutions and organ perfusion...
/PRNewswire/ -- Bridge to Life, Ltd. ("Bridge to Life" or the "Company"), a leading global supplier of organ preservation solutions and organ perfusion...
Share this article Share this article NEW YORK, Feb. 24, 2021 /PRNewswire/ -- Award winning market research company Fact.MR has recently published a report on the global serological transplant diagnostics market. According to the study, the market is expected to receive significant impetus in 2021 as organ transplantation procedures acquire momentum after a brief lull experienced due to the COVID-19 pandemic. Long-term prospects appear modest, with Fact.MR projecting a CAGR of 2.5% through 2031. Growth is majorly underpinned by increasing incidences of nephrology disorders. According to the G...